ANGLE PLC (AGL)

Industry Diagnostics & Research

This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

7.50p

Buy

8.00p

arrow-up0.027p (+0.35%)

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.
Prices updated at 15 May 2025, 07:56 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
-
CEO
Mr. Andrew David William Newland
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
150
Head office
10 Nugent Road
Guildford
United Kingdom
GU2 7AF
mobile
+44 1483343434
letter
investor@angleplc.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Brian Howlett
Non-Executive Director, Senior Independent Director
---0.04m-
Mr. Ian Francis Griffiths
Executive Director, Finance Director and Company Secretary
-----
Mr. Andrew David William Newland
Executive Director, Chief Executive Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Chelverton Asset Management Ltd10,000,0300.20767--30 Apr 20253.10
MI Chelverton UK Equity Growth Fund10,000,0300.20767--30 Apr 20253.10
Unicorn Asset Management Ltd2,769,2300.12004--30 Apr 20250.86
Unicorn AIM VCT Series 3 ORD2,769,2300.12004--30 Apr 20250.86
Hargreave Hale Limited2,200,0000.1765716393-30 Apr 20250.68

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.